The Healthcare sector +1.6% is outperforming the S&P 500 +1.1%.
News: SHP +22% announced an up to $10 million share repurchase program, MNKD +20% announced that it has confirmed with the U.S. FDA the design of two clinical studies that evaluate the efficacy and safety of AFREZZA, NEPH +18% files 510(k) application for Hemodiafiltration System, ASTM +5% announced adoption of shareholder rights plan, TSPT +2.7% announces FDA update, MYL +2.5% generic version of Uroxatral tablets, BKD +1.6% approves a share repurchase program that authorizes purchase up to $100 mln in the aggregate common stock, PGNX -2.2% files $100 mln mixed securities shelf offering, and ARNA -3% to rejoin Arena Pharmaceuticals as Vice President, Finance and CFO.
Broker Research: MNKD +20% upgraded at JMP Securities, PTX +6.5% initiated at Stifel, EW +5.6% upgraded at Credit Suisse, ASTM +5.3% initiated at Global Hunter, and BDX +2% upgraded at Mizuho.






